Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Sarcoma × Pemetrexed × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 174 Lung Neoplasms 63 Neoplasms 21 Adenocarcinoma of Lung 14 Mesothelioma, Malignant 13 Neoplasm Metastasis 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Mesothelioma 10 Carcinoma 9 Head and Neck Neoplasms 8 Breast Neoplasms 8 Recurrence 5 Ovarian Neoplasms 5 Adenocarcinoma, Bronchiolo-Alveolar 5 Small Cell Lung Carcinoma 4 Colorectal Neoplasms 4 Adenocarcinoma 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Lung Diseases 3 Carcinoma, Small Cell 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thoracic Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Respiratory Tract Neoplasms 2 Osteosarcoma 2 Non-Squamous Non-Small Cell Lung Cancer 2

Interventions

Doxorubicin 29 Ifosfamide 19 pazopanib 15 Gemcitabine 14 Cyclophosphamide 13 pembrolizumab 10 Sirolimus 9 Radiotherapy 9 Docetaxel 9 Vincristine 8 Irinotecan 8 Filgrastim 8 Sorafenib 7 Etoposide 7 Bevacizumab 7 temsirolimus 6 olaratumab 5 eribulin 5 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Mesna 5 Magnetic Resonance Spectroscopy 5 tazemetostat 4 Temozolomide 4 Radiation 4 Ipilimumab 4 Dexrazoxane 4 Dactinomycin 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00860015 2020-08-25

Alimta Plus Gemcitabine for Advanced Sarcoma

Columbia University

Phase 2 Completed

12 enrolled 4 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡